Fundamentals of SGLT2i's and GLP-1RA's for CV Risk

Fundamentals of SGLT2i's and GLP-1RA's for CV Risk
1 year 17 Views
Category:
Description:

 

Listen to Expert Faculty discuss the fundamental science and the mechanism to evidence around new antihyperglycemic drugs, and why exactly this is such an important topic. This conversation focuses on the key principles of adding GLP-1 RAs and SGLT2 inhibitors, and how using these drugs has been shown to have an important effect on reducing cardiovascular outcomes.